AMD's Chip Deals with OpenAI and Meta Trigger Over $1 Billion in Non-Cash Charges
nashnova research
AMD booked a $1.07 billion non-cash charge in Q3 as warrants granted to OpenAI and Meta began to vest — yet shares still rose roughly 8% after hours, with the market reading the cost as the price of locking in two marquee AI customers.
Where does this $1 billion charge come from?
AMD signed major chip-supply agreements with OpenAI and Meta, granting each the right to acquire up to 10% of AMD's equity via warrants — options to buy stock at a near-zero price.
As chip deliveries accelerated, the warrants entered their amortization period. The Q3 hit: $1.07 billion in non-cash charges, or $0.66 per share, dragging down GAAP profit.
This means → no cash left the building. The charge is an accounting recognition of the "equity-for-orders" trade-off; the balance sheet didn't shrink, but reported earnings did.
Why did the stock rally 8% on a profit hit?
The market looked past the charge to the signal behind it: AMD has locked in long-term order commitments from two of the biggest AI spenders on the planet.
AMD shares climbed roughly 8% after hours; Intel, Nvidia, and Broadcom rose in sympathy.
In plain terms = investors ran the math — "give up $1 billion on paper today, secure years of steady AI chip shipments" — and decided the trade was worth it.
How much dilution could existing shareholders face?
Both sets of warrants vest only after OpenAI and Meta hit shipment-volume and other commercial milestones. AMD expects to give clearer guidance on timing no earlier than 2027.
A key difference: OpenAI's warrants carry an AMD share-price threshold; Meta's do not.
If fully exercised, both companies could theoretically buy large AMD stakes at just one cent per warrant — actual dilution depends on AMD's share price at that point.
This means → the dilution risk is real, but exercising requires clearing volume and price hurdles. This is not a giveaway.
Is this "equity-for-orders" model common in the industry?
Multiple precedents exist: Cerebras granted warrants to OpenAI tied to a $20 billion purchase commitment; Marvell granted warrants to Alphabet tied to $12.2 billion in potential equity; Qualcomm granted warrants to Amazon inside a $60 billion AI data-center chip deal.
This reflects a new commercial pattern in AI chips: using equity incentives to lock in long-term procurement, blurring the lines between customer, supplier, and investor.
Put simply = chip companies are telling big buyers, "The more chips you buy, the cheaper you get to become our shareholder" — turning customers into stakeholders.
What does this mean for Nvidia's dominance?
Analyst Bob O'Donnell argues the warrant incentives played a role in some sales, but the deeper driver is pent-up demand for an Nvidia alternative.
AMD's products are becoming competitive on price-performance, and the deals are seen as a major endorsement of AMD's AI chip and software capabilities.
Analysts broadly agree, however, that this is unlikely to dislodge Nvidia's market leadership — AMD is capturing incremental share, not replacing installed base.
What should investors watch next?
2027 is the key date: AMD will offer clearer guidance on when warrant-vesting conditions may be met — the pivot point for sizing actual dilution.
AMD also struck a chip-procurement arrangement with Anthropic, but that deal includes an AMD investment commitment in Anthropic, making its structure different from the OpenAI and Meta agreements.
This means → when the vesting conditions are satisfied and where dilution ultimately lands are the core variables the market will track through 2027.
市场有风险，内容仅供研究参考，不构成投资建议。